Athyrium Capital Management as of June 30, 2023
Portfolio Holdings for Athyrium Capital Management
Athyrium Capital Management holds 7 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biora Note 7.250% 12/0 (Principal) | 39.2 | $61M | 104M | 0.58 | |
| Omeros Corp Note 5.250% 2/1 (Principal) | 34.2 | $53M | 72M | 0.73 | |
| Omeros Corp Note 6.250%11/1 (Principal) | 7.2 | $11M | 11M | 1.00 | |
| Paratek Pharmaceuticals Note 4.750% 5/0 (Principal) | 5.7 | $8.8M | 9.0M | 0.98 | |
| Rvl Pharmaceuticals SHS (RVLPQ) | 5.3 | $8.2M | 15M | 0.56 | |
| Biora Therapeutics Ord (BIOR) | 4.2 | $6.5M | 1.7M | 3.85 | |
| Puma Biotechnology (PBYI) | 4.1 | $6.3M | 1.8M | 3.53 |
